ALK and neuroblastoma: Our work has expanded on the findings of previously published studies investigating ALK inhibitor resistance mechanisms in NB13,52; AXL activation was identified by a phospho-proteomic assay in NB cell lines rendered resistant to ALK inhibitors through continuous exposure to increasing concentrations of drugs52, whereas MYCN overexpression was reported as a resistance mechanism in another study13.